eDruginfo.com
Wolters Kluwer | Lippencott Williams & Wilkins
Drug Updates | New Indications

   Drug Updates
       New Drugs
       New Indications
   Patient Teaching

   News Capsules

   Drug Warnings

   Herbal Spotlight

   Quik Tools

   Drug Info Links

   Drug Info Bookstore

   Feedback

   Registration

   Disclaimer



aripiprazole
Abilify Pharmaceutical company:
Otsuka Pharmaceuticals
www.abilify.com

NEW INDICATION & DOSAGE
Treatment of schizophrenia in adolescents ages 13 to 17--
Adolescents ages 13 to 17 years: Initially, 2 mg/day P.O. Titrate to 5 mg/day after 2 days with a target dose of 10 mg/day. Maximum daily dosage is 30 mg/day.

     
   

Home - Guest Registry - Customer Service

Brought to you by Lippincott Williams & Wilkins.
For help on how you should use this site, see our
Disclaimer .

© Copyright 2008 by Lippincott Williams & Wilkins